Why Gene Therapy Is The Best Bet For Restoring Functional Vision By: Benzinga via Benzinga May 19, 2015 at 15:18 PM EDT Shares of Spark Therapeutics Inc (NASDAQ: ONCE) are up more than 35 percent since its IPO in late January. The company is engaged in ... Read More >> Related Stocks: Spark Therap